No Data
Shenzhou Cell: Shenzhou Cell 2024 Third Quarter Report
Shenzhou Cell 2024 Third Quarter Report
Sinocelltech Gets Nod to Trial Respiratory Drug; Shares Up 3%
Shenzhou Cell (688520.SH): Recombinant respiratory syncytial virus vaccine product SCTV02 injection clinical trial approved.
Shenzhou Cell (688520.SH) announced that the company has received the approval and issuance of pharmaceuticals from the National Medical Products Administration...
What Sinocelltech Group Limited's (SHSE:688520) 44% Share Price Gain Is Not Telling You
CEO Liangzhi Xie, Sinocelltech Group Limited's (SHSE:688520) Largest Shareholder Sees Value of Holdings Go Down 3.3% After Recent Drop
Subdued Growth No Barrier To Sinocelltech Group Limited's (SHSE:688520) PriceNo Data
No Data
